Read the latest positive news, breakthroughs, and inspiring stories about cancer treatment breakthrough, curated daily by BrightWire.
A University of Toledo researcher just won an $80,000 grant to crack one of cancer's toughest puzzles: why pancreatic tumors resist treatment. His approach targets how cancer cells fuel themselves under stress.
Researchers at IIT BHU discovered a chemical compound that destroys breast cancer cells while leaving healthy tissue untouched, offering hope for treatments without chemotherapy's harsh side effects. The molecule targets two key proteins cancer cells need to survive, essentially starving them and triggering self-destruction.
A breakthrough drug targeting previously "undruggable" KRAS mutations has approximately doubled survival time for metastatic pancreatic cancer patients compared to chemotherapy. The development marks a historic shift for a disease that affects over 90% of pancreatic cancer cases. ---
A breakthrough treatment for aggressive endometrial cancer significantly extended survival in clinical trials, offering hope for patients who've run out of options. This marks the first time any drug of its kind has outperformed chemotherapy for this increasingly deadly cancer.
A groundbreaking clinical trial shows that adding an antibody called NP137 to standard chemotherapy helped patients with advanced pancreatic cancer live significantly longer. The treatment worked by blocking a protein that makes tumors resistant to chemotherapy.
Researchers at University of Chicago discovered why a mutation makes adult leukemia so resistant to treatment and identified a strategy that could extend survival by a year. The breakthrough could reshape how doctors treat one in 10 adult leukemia patients.
Scientists at Oregon Health & Science University created a molecule that shuts down a key enzyme cancer cells need to grow, causing tumors to shrink in mice with triple-negative breast cancer. The breakthrough could lead to new treatments for one of the deadliest forms of breast cancer.
Scientists have discovered an antibody that successfully halted triple-negative breast cancer in laboratory models, offering hope for one of the most difficult cancers to treat. This breakthrough could lead to better treatment options for thousands of women facing this aggressive disease.